BTC $78,786.00 -0.26%
ETH $2,489.57 +1.05%
BNB $702.68 +1.03%
XRP $1.41 -2.26%
SOL $101.02 +4.07%
TRX $0.3341 -0.96%
DOGE $0.0867 +0.13%
ADA $0.2087 -1.17%
BCH $266.39 -0.48%
LINK $11.50 +0.84%
HYPE $81.15 -0.38%
AAVE $124.55 -2.72%
SUI $0.7489 -1.41%
XLM $0.1826 -0.91%
ZEC $778.48 -0.65%
BTC $78,786.00 -0.26%
ETH $2,489.57 +1.05%
BNB $702.68 +1.03%
XRP $1.41 -2.26%
SOL $101.02 +4.07%
TRX $0.3341 -0.96%
DOGE $0.0867 +0.13%
ADA $0.2087 -1.17%
BCH $266.39 -0.48%
LINK $11.50 +0.84%
HYPE $81.15 -0.38%
AAVE $124.55 -2.72%
SUI $0.7489 -1.41%
XLM $0.1826 -0.91%
ZEC $778.48 -0.65%

生物制药上市公司 ATAI Life Sciences 计划初步投资 500 万美元购买比特币

2025-03-21 08:46:06

ChainCatcher 消息,据 CoinDesk 报道,生物制药上市公司 ATAI Life Sciences 宣布将采用比特币财务战略,计划初步投资 500 万美元购买比特币。受该消息影响,ATAI 股价短暂上涨。

该公司董事长 Christian Angermayer 表示,该公司初步计划投资 500 万美元购买比特币,同时将保留足够的现金、短期证券和公开股权,以保障公司运营资金至 2027 年。

app_icon
ChainCatcher Building the Web3 world with innovations.